SOX2 and renal cell carcinoma: We found that CD133+cells in RCC and NK were uniformly negative for the hematopoietic stem cell markers CD31 or CD45 but were strongly and persistently positive for stem cell markers (Oct4, Sox2, Nanog and Lin28) and for vimentin [41].